I don't know, there was some good in there too. Now that the new facilities and labs are operational and the move is behind us lets see what happens over the next couple of qtrs. Assets are way up, cash in bank (at the time anyway), debt reduced significantly. So the qtr was bad, I expected this.
If we see some nice growth next qtr as they predict, we'll be in much better shape. Now is not the time to sell this, if i did not already have such a large position i would be buying right here.
Too bad they can not network with some big players in this region. Many of them could foot the bill and slam this through the FDA with out even feeling it, it would be for a very good cause.